XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
OPERATING ACTIVITIES          
Net income $ 647 $ 2,102 $ 1,975 $ 6,501  
Adjustments to reconcile net income to net cash provided by operating activities:          
Provision (credit) for credit losses 189 500 1,411 (225)  
Depreciation and amortization expense     1,543 1,531  
Amortization expense of core deposit intangible     21 23  
Amortization of fair value adjustment on acquired time deposits     (29) (83)  
Net amortization of investment securities     43 98  
Net amortization of deferred loan fees     (83) (486)  
Net gains on loans held for sale     (123) (183)  
Origination of mortgage loans held for sale     (6,441) (8,239)  
Sales of mortgage loans held for sale     6,623 9,405  
Increase in accrued interest receivable     (846) (636)  
Increase (decrease) in accrued interest payable     2,069 (571)  
Earnings on bank-owned life insurance (321) (329) (802) (769)  
Deferred income taxes     (166) 601  
Stock compensation expense     35 38  
Net change in operating leases     (48) (69)  
Other, net     (4) (5,082)  
Net cash provided by operating activities     5,178 1,854  
INVESTING ACTIVITIES          
Purchase of investment securities - available for sale     (11,771) (49,372)  
Purchase of investment securities - held to maturity     (2,943) (11,104)  
Proceeds from maturities of investment securities - available for sale     15,216 15,755  
Proceeds from maturities of investment securities - held to maturity     4,457 2,244  
Proceeds from sales of investment securities - available for sale 0 1,500 0 1,519  
Purchase of regulatory stock     (15,747) (4,405)  
Proceeds from redemption of regulatory stock     16,579 3,190  
Long-term loans originated     (140,065) (163,679)  
Principal collected on long-term loans     128,421 168,215  
Purchases of premises and equipment     (1,010) (1,621)  
Proceeds from sale of other real estate owned and repossessed assets     39 14  
Proceeds from life insurance policies     387 670  
Net cash used in investing activities     (6,437) (38,574)  
FINANCING ACTIVITIES          
Net increase in deposit balances     20,782 13,518  
Net (decrease) increase in other short-term borrowings     (25,190) 26,274  
Principal borrowings on advances from Federal Home Loan Bank     17,920    
Principal repayments on advances from Federal Home Loan Bank     (15,568) (14,131)  
Principal payments on financing lease liabilities     (171) (163)  
Stock options exercised     94 91  
Common stock dividend paid     (1,542) (1,454)  
Net cash (used in) provided by financing activities     (3,675) 24,135  
NET DECREASE IN CASH AND CASH EQUIVALENTS     (4,934) (12,585)  
CASH AND CASH EQUIVALENTS AT JANUARY 1     22,962 41,101 $ 41,101
CASH AND CASH EQUIVALENTS AT SEPTEMBER 30 $ 18,028 $ 28,516 $ 18,028 $ 28,516 $ 22,962